Inositol Side Effects: What Shows Up, at What Dose, and When to Stop

What Actually Shows Up, and at What Dose?

Twelve controlled trials that dosed myo-inositol from 4 to 30 grams a day, covering more than 250 people over periods of one month to a year, found gastrointestinal symptoms only at 12 g a day or higher — nausea, flatus, and loose stools or diarrhea, described as mild in every trial that reported them. Below that dose, across every trial reviewed, nothing was reported at all.

None of the trials behind this specific data were run in women with PCOS — they tested myo-inositol for conditions like depression, panic disorder, psoriasis, and erectile dysfunction, at doses up to 30 g/day, specifically to map out its general human tolerability. That is still a reasonable way to build a tolerability picture — gastrointestinal absorption of a sugar-alcohol-like molecule works the same way regardless of why someone is taking it — but it does mean the rows below tell you about inositol’s ceiling in general, not about PCOS trials specifically; the PCOS-specific dose is covered next.

Notice that even the 4 g/day row here — Agostini’s trial, run in men, for an unrelated condition — reported only two cases of mild insomnia and one of flatus, nothing worse. That lines up with the PCOS-specific data on the same dose, covered next.

Is the 4 g PCOS Dose Actually Free of Side Effects?

A separate double-blind trial of exactly 4 g of myo-inositol a day, run for 12 to 16 weeks in 42 women with PCOS, reported real hormonal and metabolic change — a 65% drop in total testosterone, 70% ovulation versus 21% on placebo — with no gastrointestinal complaints noted in the published results. The 2011 safety review’s own summary of the wider clinical evidence at this dose states it plainly: “the dosage of 4 g/day of inositol commonly used in clinics is completely free of side effects”. That is a stronger, more specific statement than most supplements can back up, and it is worth taking at face value — while remembering it describes trial-monitored use of one specific, verified dose, not every product on a shelf claiming to contain it. A powder measured out to 4 g and a capsule product with an unlabelled “proprietary blend” are not the same guarantee — only the first is what the trials above actually tested. Inositol is sold as a dietary supplement rather than a regulated medicine in most countries, so product quality and labelling accuracy vary by manufacturer in a way a prescription drug’s would not; nothing here should be read as evidence that inositol cures or reverses PCOS, only that the studied dose has a clean tolerability record.

Does Inositol Cause Nausea?

Nausea was the single most frequently reported symptom across the higher-dose trials, appearing at 12 g a day and above but not reported at all in the 4 g/day trials, whether run in PCOS or other conditions. Where it did appear, it was consistently described as mild, and in the longest tolerability study in the table — an 18 g/day arm followed for three months — mild gastrointestinal symptoms were only experienced in the first month, suggesting some tolerance builds even at the doses where symptoms exist at all. If nausea does show up at a normal PCOS dose, splitting it into two smaller servings with food is a reasonable first adjustment, since none of the reviewed trials found that severity worsened with time or higher doses — only that it appeared at all above a threshold.

Does Inositol Cause Hair Loss?

Zero of the trials reviewed above list hair loss as a reported adverse event, at any dose from 4 to 30 grams a day. That absence is worth stating plainly because it is genuinely reassuring, not because the question has been studied directly — no PCOS trial has used hair growth or shedding as a measured outcome for inositol, so there is no dedicated data either confirming or ruling it out. What the trial evidence does show is a testosterone-lowering trend across pooled PCOS studies (SMD −0.49, just short of statistical significance) — androgen-driven hair thinning would, if anything, be expected to move in the opposite direction from what a side effect would look like. If you are dealing with hair shedding alongside PCOS, the causes and what actually regrows it are covered in PCOS hair loss, which is a separate question from inositol’s tolerability.

Does It Matter if My Product Combines Myo-Inositol With D-Chiro-Inositol?

The 12 g/day threshold above tracks total inositol dose, not which isomer or ratio it is delivered in — none of the reviewed safety trials isolated D-chiro-inositol’s gastrointestinal profile separately from myo-inositol’s. A combination product’s D-chiro-inositol component is typically a small fraction of the total (100 mg against 4,000 mg of myo-inositol in a 40:1 formula, for example), so it is not the variable driving tolerability either way. If you are deciding between a myo-inositol-only product and a combination formula, that decision is about the ratio and what it changes biologically, not about side effects, and it is covered fully in myo-inositol vs D-chiro-inositol.

You may see the condition referred to as polyendocrine metabolic ovarian syndrome (PMOS), the name a 2026 global consensus of 56 organisations adopted for PCOS. None of the safety data above changed with the rename — see PCOS is now PMOS for what did.

Who Should Be Extra Cautious, or Call a Doctor?

Three groups deserve a conversation with a prescriber before starting, rather than after a problem shows up: anyone with an existing gastrointestinal condition where nausea or diarrhea would be hard to distinguish from a flare, anyone pregnant or breastfeeding (none of the trials in Table 1 enrolled these groups, so there is nothing to reassure you with either way), and anyone already taking metformin or another insulin-sensitising medicine, since combined effects on insulin have not been formally studied. A fourth practical group: anyone starting at a dose above 4 g/day without easing into it — none of the trials above tested a rapid jump straight to 12 g or higher, so a slower build-up is the more conservative approach if a higher dose is what you and your prescriber land on.

What Long-Term Safety Data Does — and Does Not — Exist?

Twelve months is the longest duration any myo-inositol trial in the 2011 safety review’s own compiled data has run; most PCOS-specific ovulation trials are considerably shorter — the one that tracked ovulation and pregnancy outcomes ran 6 months. A 2024 systematic review feeding the 2023 international guideline reached a similarly bounded conclusion: myo-inositol likely causes fewer gastrointestinal adverse events than metformin, and these are typically mild and self-limited — but the review covered the same short-to-medium trial durations as everything above it. Multi-year use has simply not been studied. That is not the same as evidence of harm; it means anything beyond about a year of daily use sits outside what any published trial has actually tracked, and an honest answer says so instead of assuming safety scales indefinitely with a good one-year record.

Your Next Step

One number is worth confirming before you take anything: the milligrams of inositol per serving on your specific product, checked against the 4 g/day figure that carries the cleanest safety record in the trials above. For how much to actually take and how long to give it, see inositol for PCOS; for everything else worth ruling in or out, the supplements and medications section covers the rest.